cdifffoundation.org
Actelion Pharmaceuticals Ltd Antibiotic Cadazolid receives US FDA Qualified Infectious Disease product for treatment of C. diff.-associated diarrhea (CDAD)
* In The News * * Full article ALLSCHWIL/BASEL, SWITZERLAND – 27 February 2014 – Actelion Ltd (SIX: ATLN) today (27/2/2014) announced that the US Food and Drug Administration (…